chr10-103096405-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001351169.2(NT5C2):c.772-425C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0884 in 152,240 control chromosomes in the GnomAD database, including 841 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.088 ( 841 hom., cov: 31)
Consequence
NT5C2
NM_001351169.2 intron
NM_001351169.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.65
Publications
24 publications found
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
NT5C2 Gene-Disease associations (from GenCC):
- hereditary spastic paraplegia 45Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5C2 | NM_001351169.2 | c.772-425C>T | intron_variant | Intron 11 of 18 | ENST00000404739.8 | NP_001338098.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0884 AC: 13449AN: 152122Hom.: 836 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
13449
AN:
152122
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0884 AC: 13465AN: 152240Hom.: 841 Cov.: 31 AF XY: 0.0907 AC XY: 6755AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
13465
AN:
152240
Hom.:
Cov.:
31
AF XY:
AC XY:
6755
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
1624
AN:
41558
American (AMR)
AF:
AC:
2080
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
254
AN:
3472
East Asian (EAS)
AF:
AC:
1443
AN:
5186
South Asian (SAS)
AF:
AC:
887
AN:
4828
European-Finnish (FIN)
AF:
AC:
790
AN:
10582
Middle Eastern (MID)
AF:
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6132
AN:
68002
Other (OTH)
AF:
AC:
218
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
600
1200
1800
2400
3000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
676
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.